CN100376583C - 喜树碱20位酯 - Google Patents

喜树碱20位酯 Download PDF

Info

Publication number
CN100376583C
CN100376583C CNB038125447A CN03812544A CN100376583C CN 100376583 C CN100376583 C CN 100376583C CN B038125447 A CNB038125447 A CN B038125447A CN 03812544 A CN03812544 A CN 03812544A CN 100376583 C CN100376583 C CN 100376583C
Authority
CN
China
Prior art keywords
alkyl
group
branched
camptothecin
straight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB038125447A
Other languages
English (en)
Chinese (zh)
Other versions
CN1656101A (zh
Inventor
M·马尔齐
D·阿洛阿蒂
C·皮萨诺
M·O·廷蒂
L·韦希
F·祖尼诺
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Istituto Nazionale per lo Studio e la Cura die Tumori
Sigma Tau Industrie Farmaceutiche Riunite SpA
Original Assignee
Istituto Nazionale per lo Studio e la Cura die Tumori
Sigma Tau Industrie Farmaceutiche Riunite SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Istituto Nazionale per lo Studio e la Cura die Tumori, Sigma Tau Industrie Farmaceutiche Riunite SpA filed Critical Istituto Nazionale per lo Studio e la Cura die Tumori
Publication of CN1656101A publication Critical patent/CN1656101A/zh
Application granted granted Critical
Publication of CN100376583C publication Critical patent/CN100376583C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/22—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains four or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
CNB038125447A 2002-05-31 2003-05-28 喜树碱20位酯 Expired - Fee Related CN100376583C (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2002RM000306A ITRM20020306A1 (it) 2002-05-31 2002-05-31 Esteri in posizione 20 di camptotecine.
ITRM2002A000306 2002-05-31

Publications (2)

Publication Number Publication Date
CN1656101A CN1656101A (zh) 2005-08-17
CN100376583C true CN100376583C (zh) 2008-03-26

Family

ID=11456339

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB038125447A Expired - Fee Related CN100376583C (zh) 2002-05-31 2003-05-28 喜树碱20位酯

Country Status (21)

Country Link
US (2) US7452900B2 (https=)
EP (2) EP2112154B1 (https=)
JP (1) JP4593270B2 (https=)
KR (1) KR101000963B1 (https=)
CN (1) CN100376583C (https=)
AR (1) AR040140A1 (https=)
AT (1) ATE439362T1 (https=)
AU (1) AU2003241161C1 (https=)
CA (1) CA2487252C (https=)
CY (2) CY1109581T1 (https=)
DE (1) DE60328777D1 (https=)
DK (2) DK1509529T3 (https=)
ES (2) ES2432379T3 (https=)
IT (1) ITRM20020306A1 (https=)
MX (1) MXPA04011681A (https=)
PE (1) PE20040533A1 (https=)
PL (1) PL374009A1 (https=)
PT (2) PT2112154E (https=)
SI (2) SI2112154T1 (https=)
TW (1) TWI331151B (https=)
WO (1) WO2003101996A2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2852606A1 (fr) * 2003-03-18 2004-09-24 Inst Nat Sante Rech Med Moyens pour inhiber simultanement l'expression de plusieurs genes impliques dans une pathologie
NZ550430A (en) 2004-04-27 2009-06-26 Wellstat Biologics Corp Cancer treatment using viruses and camptothecins
ITRM20040242A1 (it) * 2004-05-13 2004-08-13 Ist Naz Stud Cura Dei Tumori "7-t-butossiimminometilcamptotecina coniugata in posizione 20 con antagonisti delle integrine.
ATE540698T1 (de) 2005-07-14 2012-01-15 Wellstat Biologics Corp Krebsbehandlung mit viren, fluoropyrimidinen und camptothecinen
CN103864811A (zh) * 2012-12-13 2014-06-18 天津科技大学 一种新颖的10-羟基喜树碱20位衍生物制备方法及其在抗肿瘤药物中的应用
US9962452B2 (en) * 2013-02-04 2018-05-08 Zhuhai Beihai Biotech Co., Ltd. Soluble complexes of drug analogs and albumin
US9937259B2 (en) 2014-06-27 2018-04-10 Zhuhai Beihai Biotech Co., Ltd. Abiraterone derivatives and non-covalent complexes with albumin
WO2016065139A1 (en) 2014-10-24 2016-04-28 Fl Therapeutics Llc 3-substituted piperidine-2, 6-diones and non-covalent complexes with albumin
US10517961B2 (en) 2015-09-25 2019-12-31 ZY Therapeutics, Inc. Drug formulation based on particulates comprising polysaccharide-vitamin conjugate
CN106279286B (zh) * 2016-08-12 2018-11-30 华中科技大学 一种喜树碱膦酸酯类化合物、其制备方法及应用
CN110577551A (zh) * 2018-06-08 2019-12-17 遵义医学院 喜树碱-甘氨酸-5,6-二溴去甲斑蝥素结合物及其应用
MX2022000474A (es) 2019-07-11 2022-03-11 Sun Pharma Advanced Res Co Ltd Derivados de camptotecina con un resto disulfuro y un resto piperazina.
CN116514829A (zh) * 2020-08-21 2023-08-01 诺茗(北京)生物医药有限公司 一种水溶性抗肿瘤前药及其药物组合物和用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4943579A (en) * 1987-10-06 1990-07-24 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Water soluble prodrugs of camptothecin
US5004758A (en) * 1987-12-01 1991-04-02 Smithkline Beecham Corporation Water soluble camptothecin analogs useful for inhibiting the growth of animal tumor cells
JP3186166B2 (ja) * 1992-02-10 2001-07-11 ロンザ リミテッド サリチロイル−カルニチンおよびその製造方法
US5646159A (en) * 1994-07-20 1997-07-08 Research Triangle Institute Water-soluble esters of camptothecin compounds
JP3751025B2 (ja) 1995-12-15 2006-03-01 ザ デクスター コーポレイション 研摩性不織繊維ウェブ材料及びその製造方法
ES2235499T3 (es) 1998-07-30 2005-07-01 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Uso de derivados de propionil l-carnitina y de acetil l-carnitina en la preparacion de medicamentos con actividad anticancerigena.
US6204257B1 (en) 1998-08-07 2001-03-20 Universtiy Of Kansas Water soluble prodrugs of hindered alcohols
ATE216998T1 (de) * 1999-03-09 2002-05-15 Sigma Tau Ind Farmaceuti Camptothecin-derivate mit antitumor-wirkung
DE19916945C1 (de) 1999-04-15 2000-10-05 Clariant Gmbh Aromatische Aldehydharze und ihre Verwendung als Emulsionsspalter
US6228855B1 (en) 1999-08-03 2001-05-08 The Stehlin Foundation For Cancer Research Aromatic esters of camptothecins and methods to treat cancers
US6288072B1 (en) 1999-12-29 2001-09-11 Monroe E. Wall Camptothecin β-alanine esters with topoisomerase I inhibition
US6629995B1 (en) 2000-03-31 2003-10-07 Super Gen, Inc. Camptothecin conjugates

Also Published As

Publication number Publication date
PE20040533A1 (es) 2004-08-26
EP1509529A2 (en) 2005-03-02
DE60328777D1 (en) 2009-09-24
TW200403246A (en) 2004-03-01
US20050256148A1 (en) 2005-11-17
ITRM20020306A1 (it) 2003-12-01
WO2003101996A8 (en) 2004-04-29
ES2432379T3 (es) 2013-12-03
CN1656101A (zh) 2005-08-17
DK2112154T3 (da) 2013-10-21
DK1509529T3 (da) 2009-12-14
CY1114692T1 (el) 2016-10-05
CA2487252A1 (en) 2003-12-11
US7498340B2 (en) 2009-03-03
US7452900B2 (en) 2008-11-18
CY1109581T1 (el) 2014-08-13
JP4593270B2 (ja) 2010-12-08
KR20050036910A (ko) 2005-04-20
AU2003241161C1 (en) 2010-03-04
AU2003241161A1 (en) 2003-12-19
US20070213353A1 (en) 2007-09-13
ES2331569T3 (es) 2010-01-08
ITRM20020306A0 (it) 2002-05-31
SI2112154T1 (sl) 2013-12-31
EP2112154B1 (en) 2013-07-24
KR101000963B1 (ko) 2010-12-13
ATE439362T1 (de) 2009-08-15
TWI331151B (en) 2010-10-01
WO2003101996A2 (en) 2003-12-11
JP2005529935A (ja) 2005-10-06
PL374009A1 (en) 2005-09-19
CA2487252C (en) 2010-08-10
PT1509529E (pt) 2009-11-13
EP2112154A1 (en) 2009-10-28
EP1509529B1 (en) 2009-08-12
SI1509529T1 (sl) 2009-12-31
HK1079206A1 (en) 2006-03-31
PT2112154E (pt) 2013-10-02
AU2003241161B2 (en) 2009-10-22
MXPA04011681A (es) 2005-03-31
WO2003101996A3 (en) 2004-01-29
AR040140A1 (es) 2005-03-16

Similar Documents

Publication Publication Date Title
US7498340B2 (en) Esters in position 20 of camptothecins
CN109311851B (zh) 二氢嘧啶基苯并氮杂䓬甲酰胺化合物
US5049668A (en) 10,11-methylenedioxy-20(RS)-camptothecin analogs
EP0418099B1 (en) Process of preparation of 10, 11-Methylenedioxy-20 (RS) camptothecin and 10, 11-methylenedioxy-20 (S) - camptothecin analog
EA029926B1 (ru) 1,2-дизамещенные 4-амино-имидазохинолины, содержащая их фармацевтическая композиция и их применение в качестве активаторов toll-подобных рецепторов 7 (варианты)
JPS6185319A (ja) 抗腫瘍剤
US5340817A (en) Method of treating tumors with anti-tumor effective camptothecin compounds
JPH10503220A (ja) 置換カンプトテシン誘導体およびその製造方法
US20120022045A1 (en) Bridged compounds as hiv integrase inhibitors
TW202527946A (zh) 三并環類化合物及其醫藥用途
CA2962863A1 (en) Substituted pyrimidine derivatives useful in the treatment of autoimmune diseases
KR20220107018A (ko) Jak 억제제로서의 트리헤테로사이클릭 화합물 및 이의 용도
CN87104596A (zh) 4(3H)-氧代-5，6，7，8-四氢吡啶并[2，3-d]嘧啶衍生物的制备方法
JP2003519234A (ja) トポイソメラーゼＩ阻害を有するカンプトテシンβ−アラニンエステル
JPH11503464A (ja) 抗腫瘍活性を有する９，１０−二置換カンプトテシン誘導体
CN112110897B (zh) 一种氘代克里唑蒂尼及其衍生物的制备方法
JP2003506332A (ja) 経口投与活性のあるビス白金錯体
CN113603689B (zh) 多环吡啶酮化合物及其药物组合物和用途
HK1079206B (en) Esters in position 20 of camptothecins
CN119060047A (zh) 氟代多羟基吲哚里西啶类化合物及其药学上可接受的盐及合成方法和糖苷酶抑制剂及应用
CN121202936A (zh) 可用于前药给药系统的整合素αvβ3抑制剂的连接体化合物及其制备方法和应用
JPH09227559A (ja) スピロ置換三環性複素環式化合物
JPWO2000043000A1 (ja) プロテアソーム阻害剤

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1079206

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1079206

Country of ref document: HK

CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080326

Termination date: 20180528

CF01 Termination of patent right due to non-payment of annual fee